Red‐blood‐cell manufacturing methods and storage solutions differentially induce pulmonary cell activation. Issue 5 (12th March 2020)

• Record Type: Journal Article
• Authors: Wirtz, Mathijs R.; Almizraq, Ruqayyah J.; Weber, Nina C.; Norris, Philip J.; Pandey, Suchitra; Spinella, Philip C.; Muszynski, Jennifer A.; P. Acker, Jason; Juffermans, Nicole P.
• Is Part Of: Vox sanguinis. Volume 115:Issue 5(2020)
• Page Start: 395
• Page End: 404
• Publication Date: 2020-03-12
• Subjects: blood processing -- cytokine and chemokine production -- extracellular vesicles -- mechanical ventilation -- thrombin generation; Blood -- Periodicals; Blood -- Transfusion -- Periodicals; Immunohematology -- Periodicals; Immunopathology -- Periodicals; 615.39
• DOI: 10.1111/vox.12911
• Languages: English
• ISSNs: 0042-9007

Abstract

Abstract : Background and Objectives: Red‐blood‐cell (RBC) transfusion is associated with lung injury, which is further exacerbated by mechanical ventilation. Manufacturing methods of blood products differ globally and may play a role in the induction of pulmonary cell activation through alteration of the immunomodulatory property of the products. Here, the effect of different manufacturing methods on pulmonary cell activation was investigated in an in vitro model of mechanical ventilation. Materials and Methods: Pulmonary type II cells were incubated with supernatant from fresh and old RBC products obtained via whole blood filtration (WBF), red cell filtration (RCF), apheresis‐derived (AD) or whole blood‐derived (WBD) methods. Lung cells were subjected to 25% stretch for 24 h. Controls were non‐stretched or non‐incubated cells. Results: Fresh but not old AD products and WBF products induce lung cell production of pro‐inflammatory cytokines and chemokines, which was not observed with WBD or RCF products. Effects were associated with an increased amount of platelet‐derived vesicles and an increased thrombin‐generating capacity. Mechanical stretching of lung cells induced more severe cell injury compared to un‐stretched controls, including alterations in the cytoskeleton, which was further augmented by incubation with AD products. In all read‐out parameters, RCF products seemed to induce less injury compared to the other products. Conclusions: Our findings show that manufacturing methods of RBC products impact pulmonary cell activation, which may be mediated by the generation of vesicles in the product. We suggest RBC manufacturing method may be an important factor in understanding the association between RBC transfusion and lung injury.